| (Values in U.S. Thousands) | Aug, 2025 | May, 2025 | Feb, 2025 | Aug, 2024 | May, 2024 |
| Sales | 11 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -1,305 | -544 | -818 | -459 | -359 |
| Net Income Growth | -139.74% | +33.43% | -78.31% | -27.67% | +36.09% |
Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring, and developing raw materials for pharmaceutical products. The company's products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD, and V-Gas.
Fiscal Year End Date: 11/30